Literature DB >> 19657052

The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway.

Nirmala Devi Kanika1, Moses Tar, Yuehong Tong, Dwaraka Srinivasa Rao Kuppam, Arnold Melman, Kelvin Paul Davies.   

Abstract

Intracorporal injection of plasmids encoding opiorphins into retired breeder rats can result in animals developing a priapic-like condition. Microarray analysis demonstrated that following intracorporal gene transfer of plasmids expressing opiorphins the most significantly upregulated gene in corporal tissue was the ornithine decarboxylase gene (ODC). Quantitative RT-PCR confirmed the upregulation of ODC, as well as other genes involved in polyamine synthesis, such as arginase-I and -II, polyamine oxidase, spermidine synthase, spermidine acetyltransferase (SAT), and S-adenosylmethionine decarboxylase. Western blot analysis demonstrated upregulation of arginase-I and -II, ODC, and SAT at the protein level. Levels of the polyamine putrescine were upregulated in animals treated with opiorphin-expressing plasmids compared with controls. A direct role for the upregulation of polyamine synthesis in the development of the priapic-like condition was supported by the observation that the ODC inhibitor 1,3-diaminopropane, when added to the drinking water of animals treated with plasmids expressing opiorphins, prevented experimental priapism. We also demonstrate that in sickle cell mice, another model of priapism, there is increased expression of the mouse opiorphin homologue in corporal tissue compared with the background strain at a life stage prior to evidence of priapism. At a life stage when there is onset of priapism, there is increased expression of the enzymes involved in polyamine synthesis (ODC and arginase-I and -II). Our results suggest that the upregulation of enzymes involved in the polyamine synthetic pathway may play a role in the development of experimental priapism and represent a target for the prevention of priapism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657052      PMCID: PMC2770744          DOI: 10.1152/ajpcell.00656.2008

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  40 in total

1.  Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.

Authors:  Dhananjay K Kaul; Xiaoqin Zhang; Trisha Dasgupta; Mary E Fabry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

2.  Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat.

Authors:  A Melman; G Biggs; K Davies; W Zhao; M T Tar; G J Christ
Journal:  Gene Ther       Date:  2008-01-17       Impact factor: 5.250

3.  Effects of spermine on the relaxation response of rat detrusor smooth muscles.

Authors:  Soon Chul Myung; Seung Young Oh; Kyung Do Kim; Sae Chul Kim; Moo Yeol Lee
Journal:  Eur J Pharmacol       Date:  2007-06-29       Impact factor: 4.432

Review 4.  Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator.

Authors:  Anthony E Pegg
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-18       Impact factor: 4.310

5.  Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling.

Authors:  Tiejuan Mi; Shahrzad Abbasi; Hong Zhang; Karen Uray; Janci L Chunn; Ling Wei Xia; Jose G Molina; Norman W Weisbrodt; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

6.  Testosterone regulates erectile function and Vcsa1 expression in the corpora of rats.

Authors:  Rowena G Chua; Giulia Calenda; Xinhua Zhang; Joseph Siragusa; Yuehong Tong; Moses Tar; Memduh Aydin; Michael E DiSanto; Arnold Melman; Kelvin P Davies
Journal:  Mol Cell Endocrinol       Date:  2009-02-13       Impact factor: 4.102

7.  Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells.

Authors:  Paola Salvatore; Amelia Casamassimi; Linda Sommese; Carmela Fiorito; Alfredo Ciccodicola; Raffaele Rossiello; Bice Avallone; Vincenzo Grimaldi; Valerio Costa; Monica Rienzo; Roberta Colicchio; Sharon Williams-Ignarro; Caterina Pagliarulo; Maria Evelina Prudente; Ciro Abbondanza; Florentia Lamberti; Adone Baroni; Elisabetta Buommino; Bartolomeo Farzati; Maria Antonietta Tufano; Louis Joseph Ignarro; Claudio Napoli
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

8.  The opiorphin gene (ProL1) and its homologues function in erectile physiology.

Authors:  Yuehong Tong; Moses Tar; Arnold Melman; Kelvin Davies
Journal:  BJU Int       Date:  2008-04-10       Impact factor: 5.588

9.  hSMR3A as a marker for patients with erectile dysfunction.

Authors:  Yuehong Tong; Moses Tar; Val Monrose; Michael DiSanto; Arnold Melman; Kelvin P Davies
Journal:  J Urol       Date:  2007-05-23       Impact factor: 7.450

10.  Transcription of G-protein coupled receptors in corporeal smooth muscle is regulated by the endogenous neutral endopeptidase inhibitor sialorphin.

Authors:  Yuehong Tong; Scott I Tiplitsky; Moses Tar; Arnold Melman; Kelvin P Davies
Journal:  J Urol       Date:  2008-06-13       Impact factor: 7.450

View more
  28 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathways.

Authors:  Nirmala D Kanika; Jinsook Chang; Yuehong Tong; Scott Tiplitsky; Juan Lin; Elizabeth Yohannes; Moses Tar; Mark Chance; George J Christ; Arnold Melman; Kelvin D Davies
Journal:  BJU Int       Date:  2010-09-21       Impact factor: 5.588

Review 3.  Stuttering priapism: insights into pathogenesis and management.

Authors:  Belinda F Morrison; Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

4.  Nitrergic Mechanisms for Management of Recurrent Priapism.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  Sex Med Rev       Date:  2015-06-04

5.  How I treat priapism.

Authors:  Uzoma A Anele; Brian V Le; Linda M S Resar; Arthur L Burnett
Journal:  Blood       Date:  2015-03-25       Impact factor: 22.113

6.  Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Tongyun Liu; Sena F Sezen; Arthur L Burnett
Journal:  J Sex Med       Date:  2012-05-23       Impact factor: 3.802

Review 7.  Medical management of ischemic stuttering priapism: a contemporary review of the literature.

Authors:  Helen R Levey; Omer Kutlu; Trinity J Bivalacqua
Journal:  Asian J Androl       Date:  2011-11-07       Impact factor: 3.285

Review 8.  Management of priapism: an update for clinicians.

Authors:  Helen R Levey; Robert L Segal; Trinity J Bivalacqua
Journal:  Ther Adv Urol       Date:  2014-12

9.  Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells.

Authors:  Shibo Fu; Moses Tarndie Tar; Arnold Melman; Kelvin Paul Davies
Journal:  FASEB J       Date:  2014-05-06       Impact factor: 5.191

Review 10.  A pathophysiology-based approach to the management of early priapism.

Authors:  Jason R Kovac; Siu K Mak; Maurice M Garcia; Tom F Lue
Journal:  Asian J Androl       Date:  2012-12-03       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.